Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,072.72
-4.6323-0.22%
Number of Gainers:388
Number of Losers:619
Number of Flat:17
PE:- -
High:2,088.77
Open:2,077.40
Low:2,070.10
Close:2,077.35
Volume:4.94B
Turnover:647.60B
Market Cap:96.59T
Float Cap:90.42T

Loading ...

ADP Management to Present at Citi Global TMT Conference

Reuters
·
Aug 27

AGCO CEO, CFO to Speak at Citi Global TMT Conference Fireside Chat

Reuters
·
Aug 27

NASDAQ Verafin Partners with Q6 Cyber to Add Dark Web Fraud Intelligence to Bank Platform

Reuters
·
Aug 27

Best Buy Beats Quarterly Estimates on Strong Computer Sales, Raises Full-Year Forecast

Deep News
·
Aug 27

Expion Energy Names Robert Winspear CFO, Replacing Shawna Bowin

Reuters
·
Aug 27

Red Violet to Present at Citi Global TMT Conference

Reuters
·
Aug 27

GoldHaven Starts Maiden Drilling at Magno Project’s Kuhn Tungsten Target in British Columbia

Reuters
·
Aug 27

Scholar Rock to Present at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Verrica Completes Enrollment in Phase 3 COVE-2 Trial of Ycanth for Common Warts, Sees Data in Q1 2027

Reuters
·
Aug 27

Enviri Management to Attend Jefferies Global Industrials Conference

Reuters
·
Aug 27

Marqeta CEO Milotich to Speak at Goldman Sachs Communacopia + Technology Conference Fireside Chat

Reuters
·
Aug 27

Apollo, KKR Form Partnership to Back Atlantic Aviation Growth, Valuing Firm Near $10 Billion

Reuters
·
Aug 27

ICE’s NYSE Texas Opens Dallas Headquarters at Old Parkland Campus

Reuters
·
Aug 27

Nordson Raises Quarterly Dividend 15% to $0.94 a Share

Reuters
·
Aug 27

Alvotech Executives to Speak at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Nvidia Results, Semiconductor Rally Lift US Equity Futures Pre-Bell

MT Newswires Live
·
Aug 27

Equinix Commits Additional $50 Million to the Equinix Foundation, Doubling Its Investment in Communities Worldwide

THOMSON REUTERS
·
Aug 27

MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Once-Weekly Canvuparatide for Hypoparathyroidism

Reuters
·
Aug 27

Milestone Pharmaceuticals Study Finds PSVT Curbs Daily Activities, Drives Anxiety Between Episodes

Reuters
·
Aug 27

Okta Management to Present at Goldman Sachs Communacopia & Technology Conference

Reuters
·
Aug 27